- Research
- Open Clinical Trials
- Closed Clinical Trials
- 2022-2026 Research Strategy
- Research Achievements
- Publications
- Research Development and Funding
- BCT Trials & Projects Summary
- Clinical Fellowship Program
- International Fellowship Support
- Translational Research
- What is a Clinical Trial?
- Why Participate in a Clinical Trial?
- Research Blog
- Participating Institutions
- International Collaboration
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
Neo-N
Closed
BCT 1902: Neo-N
BCT Study Chair:
Sherene Loi
The Neo-N clinical trial will investigate if using an immunotherapy drug together with chemotherapy, is safe and effective in treating breast cancer before surgery in women and men with early triple negative breast cancer.
1 (Italy)
INTERNATIONAL
Total number of trial
participants internationally
110
AUSTRALIA & NEW ZEALAND
Total number of trial participants
in Australia and New Zealand
18
INSTITUTIONS
Total number of participating institutions
in Australia and New Zealand
Neo-N PUBLICATIONS
Institutions
-
NSW
-
QLD
-
SA
-
VIC
-
WA
-
New Zealand
-
Italy
ICS MaugeriIRST MeldolaIstituto Europeo di OncologiaS.C. Oncologia ASO